首页> 美国卫生研究院文献>other >Integrating Image-Based Design and 3D Biomaterial Printing to create Patient Specific Devices within a Design Control Framework for Clinical Translation
【2h】

Integrating Image-Based Design and 3D Biomaterial Printing to create Patient Specific Devices within a Design Control Framework for Clinical Translation

机译:将基于图像的设计与3D生物材料打印相集成以在针对临床翻译的设计控制框架内创建针对患者的设备

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite significant advances in 3D biomaterial printing, the potential of 3D printing for patient specific implants and tissue reconstruction has not been fully exploited. This is due in part to the lack of integration of image-based patient specific design with 3D biomaterial printing within a relevant regulatory framework, namely design control, required by the FDA. In this manuscript, we describe the integration of image-based, multi-scale patient specific design with 3D biomaterial printing within a design control framework for clinical translation. Specifically, we define design inputs for patient specific implants and scaffolds, and utilize image-based patient specific design to achieve these design inputs. We then illustrate realization of these topology designed patient specific implants by laser sintering of polycaprolactone (PCL). Finally, we present initial results in large animal models using 3D printed PCL implants addressing two challenging problems in tissue reconstruction: 1) designing and 3D printing implantable devices to allow growth in pediatric airway applications and 2) utilizing 3D printed scaffolds as foundations for pre-fabricated flaps to obtain vascularization and bone formation for large volume bone/soft tissue reconstruction. We illustrate these challenging problems as they need to be incorporated in design control, but as of yet there is little data to direct how growth and vascularization should be utilized in design control.
机译:尽管3D生物材料打印领域取得了重大进展,但3D打印在特定患者植入物和组织重建方面的潜力尚未得到充分开发。这部分是由于在FDA要求的相关监管框架(即设计控制)中缺乏基于图像的患者特定设计与3D生物材料打印的集成。在此手稿中,我们描述了在临床翻译的设计控制框架内将基于图像的多比例患者特定设计与3D生物材料打印的集成。具体来说,我们为患者特定的植入物和支架定义设计输入,并利用基于图像的患者特定设计来实现这些设计输入。然后,我们说明通过聚己内酯(PCL)的激光烧结实现这些拓扑设计的患者特定植入物。最后,我们使用3D打印PCL植入物解决了组织重建中的两个难题:大型动物模型的初步结果:1)设计和3D打印可植入设备以允许在儿科气道应用中生长,以及2)利用3D打印支架作为预备支架的基础制成的皮瓣可获得血管化和骨形成,用于大体积的骨骼/软组织重建。我们说明了这些具有挑战性的问题,因为它们需要纳入设计控制中,但到目前为止,尚无数据可以指导在设计控制中应如何利用生长和血管形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号